Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 302759
                    [Title] => ‘Exubera’ gets positive opinion from EMEA
                    [Summary] => PARIS — Sanofi-aventis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) issued a positive opinion recommending approval of Exubera (insulin human), an inhalable form of insulin, for the treatment of type 1 and type 2 diabetes.


                    [DatePublished] => 2005-10-20 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

NEKTAR THERAPEUTICS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 302759
                    [Title] => ‘Exubera’ gets positive opinion from EMEA
                    [Summary] => PARIS — Sanofi-aventis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) issued a positive opinion recommending approval of Exubera (insulin human), an inhalable form of insulin, for the treatment of type 1 and type 2 diabetes.


                    [DatePublished] => 2005-10-20 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

‘Exubera’ gets positive opinion from EMEA

October 20, 2005 - 12:00am

PARIS — Sanofi-aventis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) issued a positive opinion recommending approval of Exubera (insulin human),...

Science and Environment